Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medistim Director's Dealing 2022

Jan 19, 2022

3662_dirs_2022-01-19_36cdf268-9208-44d6-a5e2-5a5f61a44e78.html

Director's Dealing

Open in viewer

Opens in your device viewer

Transfer of shares to CEO

Transfer of shares to CEO

Medistim ASA has transferred 12,000 shares to Medistim CEO Kari E. Krogstad, at the last traded share price in 2021, of 367.50 NOK per share. This is in accordance with her compensation agreement with the company, as described in the Company's Annual Report. After the transfer, Kari E. Krogstad holds a total of 63,802 shares in the company and Medistim ASA holds 96,422 own shares.